Michael R Hayden bought $481K of ABCL stock

Michael R Hayden, Dir of AbCellera Biologics Inc. (ABCL), bought 46,387 shares of ABCL stock worth $481K, per an SEC Form 4 filed Aug 14, 2026.

It was an open-market purchase.

The trade happened on Aug 12, 2026, 2 days before it was made public.

ABCL has moved +11.0% since the trade date, from $10.36 to $11.49 (Nov 13, 2026 close).